jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Mar. 16, 2018

Dec. 17, 2018

jRCT2080223845

ST-605 uncontrolled open-label phase 2 study in patients with herpes simplex virus keratitis

ST-605 HSV keratitis phase 2 study

M's Science Corporation

info@m-sci.com

recruiting

40

Interventional

Uncontrolled, open-label study

2

1) Patients who are diagnosed as HSV epithelial keratitis (dendritic or geographic keratitis)
2) Patients who are 18 years old or more
3) Patients who have informed consent

18age old over
No limit

Both

Herpes simplex virus keratitis

investigational material(s)
Generic name etc : ST-605 ophthalmic gel
INN of investigational material : ganciclovir
Therapeutic category code : 131 Agents for ophthalmic use
Dosage and Administration for Investigational material : 1 drop 5 times daily for maximum 3 weeks until healing of keratitis, followed by 3 times daily for a week

Cure rate after treatment
Slit-lamp examination

M's Science Corporation

JapicCTI-183901

History of Changes

No Publication date
3 Dec. 17, 2018 (this page) Changes
2 Mar. 16, 2018 Detail Changes
1 Mar. 16, 2018 Detail